Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer.

Bo Jan NoordmanE W de Bekker-GrobP P L O CoeneE van der HarstS M LagardeJ ShapiroB P L WijnhovenJ J B van Lanschot

Published in: The British journal of surgery (2018)

Patients are willing to trade off substantial 5-year survival to achieve a reduction in the risk that oesophagectomy is necessary.

Keyphrases